BACKGROUND: New genomic technology now allows physicians to provide women with individualized and highly accurate breast cancer recurrence risk estimates that are a key factor in adjuvant (after surgery) therapy decisions. Because these genomic tests are so new, little is known about how well patients understand the tests and their results. METHOD: We interviewed 163 stage I or II breast cancer patients at a routine follow-up appointment. We assessed their health literacy (using the Rapid Estimate of Adult Learning in Medicine) as well as their knowledge of and attitudes towards a genomic test that identifies risk of recurrence in hormone receptor-positive, node-negative breast cancer (the OncoType Dx Recurrence Score). RESULTS: Women with lower health literacy recalled less of the information provided about the recurrence risk test than women with higher health literacy. Health literacy was not related to the amount of additional information women desired. Women with higher health literacy preferred to have a more active role in decisions about the test. IMPLICATIONS: Health literacy may affect women's capacity to learn about the new genomic tests as well as their desire for informed participation in their medical care.
BACKGROUND: New genomic technology now allows physicians to provide women with individualized and highly accurate breast cancer recurrence risk estimates that are a key factor in adjuvant (after surgery) therapy decisions. Because these genomic tests are so new, little is known about how well patients understand the tests and their results. METHOD: We interviewed 163 stage I or II breast cancerpatients at a routine follow-up appointment. We assessed their health literacy (using the Rapid Estimate of Adult Learning in Medicine) as well as their knowledge of and attitudes towards a genomic test that identifies risk of recurrence in hormone receptor-positive, node-negative breast cancer (the OncoType Dx Recurrence Score). RESULTS:Women with lower health literacy recalled less of the information provided about the recurrence risk test than women with higher health literacy. Health literacy was not related to the amount of additional information women desired. Women with higher health literacy preferred to have a more active role in decisions about the test. IMPLICATIONS: Health literacy may affect women's capacity to learn about the new genomic tests as well as their desire for informed participation in their medical care.
Authors: Joann Seo; Melody S Goodman; Mary Politi; Melvin Blanchard; Kimberly A Kaphingst Journal: Med Decis Making Date: 2016-02-22 Impact factor: 2.583
Authors: Ann Chen Wu; James P Kiley; Patricia J Noel; Shashi Amur; Esteban G Burchard; John P Clancy; Joshua Galanter; Maki Inada; Tiffanie K Jones; Jonathan A Kropski; James E Loyd; Lawrence M Nogee; Benjamin A Raby; Angela J Rogers; David A Schwartz; Don D Sin; Avrum Spira; Scott T Weiss; Lisa R Young; Blanca E Himes Journal: Am J Respir Crit Care Med Date: 2018-12-15 Impact factor: 21.405
Authors: Kelvin Koay; Penelope Schofield; Karla Gough; Rachelle Buchbinder; Danny Rischin; David Ball; June Corry; Richard H Osborne; Michael Jefford Journal: Support Care Cancer Date: 2013-03-19 Impact factor: 3.603
Authors: Caroline S Dorfman; Randi M Williams; Elisabeth C Kassan; Sara N Red; David L Dawson; William Tuong; Elizabeth R Parker; Janet Ohene-Frempong; Kimberly M Davis; Alexander H Krist; Steven H Woolf; Marc D Schwartz; Mary B Fishman; Carmella Cole; Kathryn L Taylor Journal: BMC Med Inform Decis Mak Date: 2010-03-03 Impact factor: 2.796
Authors: S B Haga; W T Barry; R Mills; L Svetkey; S Suchindran; H F Willard; G S Ginsburg Journal: Public Health Genomics Date: 2014-02-27 Impact factor: 2.000